Health

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, issued the following statement in response to a letter from Congressman Earl L. “Buddy” Carter (GA-01) announcing his resignation of the Chairmanship of the Subcommittee on Health.  "It’s been a pleasure working alongside Health Subcommittee Chairman Buddy Carter, who has been a long-time champion of increasing Americans’ access to care,” said Chairman Guthrie . “We thank you for your leadership on the Subcommittee on Health and your continued commitment to the health and wellbeing of Americans. I wish you well in your future endeavors and look forward to your continued work on the Health Subcommittee . ” As a result of this vacancy, Chairman Guthrie announced new Subcommittee leadership and changes to Subcommittee memberships.   The following changes to Subcommittee leadership and rosters will be enacted:   Rep. Earl L. “Buddy” Carter (GA-01) will leave the Chairmanship of the Subcommittee on Health to focus on other priorities.  Rep. Morgan Griffith (VA-09) has been appointed to Chairman of the Subcommittee on Health.  Rep. Gary Palmer (AL-06) has been appointed to Chairman of the Subcommittee on Environment.  Rep. John Joyce (PA-13) has been appointed to Chairman of the Subcommittee on Oversight and Investigations.  Rep. Neal Dunn (FL-02) has been appointed to Vice Chairman of the House Committee on Energy and Commerce.  Rep. Diana Harshbarger (TN-01) has been appointed to Vice Chair of the Subcommittee on Health.  The new Subcommittee Rosters are as follows:   Subcommittee on Commerce, Manufacturing, & Trade:   Rep. Gus Bilirakis (FL-12), Chairman  Rep. Russ Fulcher (ID-01), Vice Chairman  Rep. Neal Dunn (FL-02)   Rep. Kat Cammack (FL-03)   Rep. Jay Obernolte (CA-23)   Rep. John James (MI-10)   Rep. Cliff Bentz (OR-02)   Rep. Erin Houchin (IN-09)   Rep. Russell Fry (SC-07)   Rep. Laurel Lee (FL-15)   Rep. Tom Kean, Jr. (NJ-07)    Rep. Gabe Evans (CO-08)    Rep. Craig Goldman (TX-12)  Rep. Brett Guthrie (KY-02), Ex-Officio  Subcommittee on Communications and Technology:   Rep. Richard Hudson (NC-09), Chairman  Rep. Rick Allen (GA-12), Vice Chairman  Rep. Bob Latta (OH-05)   Rep. Morgan Griffith (VA-09)  Rep. Gus Bilirakis (FL-12)   Rep. Buddy Carter (GA-01)   Rep. Neal Dunn (FL-02)   Rep. Russ Fulcher (ID-01)   Rep. August Pfluger (TX-11)   Rep. Kat Cammack (FL-03)   Rep. Jay Obernolte (CA-23)   Rep. Erin Houchin (IN-09)   Rep. Russell Fry (SC-07)   Rep. Tom Kean, Jr. (NJ-07)    Rep. Craig Goldman (TX-12)   Rep. Julie Fedorchak (ND-AL)  Rep. Brett Guthrie (KY-02), Ex-Officio  Subcommittee on Energy:   Rep. Bob Latta (OH-05), Chairman  Rep. Randy Weber (TX-14), Vice Chairman  Rep. Gary Palmer (AL-06)   Rep. Rick Allen (GA-12)   Rep. Troy Balderson (OH-12)   Rep. August Pfluger (TX-11)   Rep. Diana Harshbarger (TN-01)   Rep. Mariannette Miller-Meeks (IA-01)   Rep. John James (MI-10)   Rep. Cliff Bentz (OR-02)   Rep. Russell Fry (SC-07)   Rep. Laurel Lee (FL-15)   Rep. Nick Langworthy (NY-23)   Rep. Michael Rulli (OH-06)   Rep. Gabe Evans (CO-08)   Rep. Craig Goldman (TX-12)   Rep. Julie Fedorchak (ND-AL)  Rep. Brett Guthrie (KY-02), Ex-Officio  Subcommittee on Environment:   Rep. Gary Palmer (AL-06), Chairman  Rep. Dan Crenshaw (TX-02), Vice Chairman  Rep. Bob Latta (OH-05)    Rep. Morgan Griffith (VA-09)   Rep. Buddy Carter (GA-01)   Rep. John Joyce (PA-13)   Rep. Randy Weber (TX-14)   Rep. August Pfluger (TX-11)   Rep. Mariannette Miller-Meeks (IA-01)   Rep. Laurel Lee (FL-15)   Rep. Nick Langworthy (NY-23)   Rep. Gabe Evans (CO-08)   Rep. Julie Fedorchak (ND-AL)  Rep. Brett Guthrie (KY-02), Ex-Officio  Subcommittee on Health:   Rep. Morgan Griffith (VA-09), Chairman  Rep. Diana Harshbarger (TN-01), Vice Chair  Rep. Gus Bilirakis (FL-12)   Rep. Buddy Carter (GA-01)   Rep. Neal Dunn (FL-02)    Rep. Dan Crenshaw (TX-02)   Rep. John Joyce (PA-13)   Rep. Troy Balderson (OH-12)   Rep. Mariannette Miller-Meeks (IA-01)   Rep. Kat Cammack (FL-03)   Rep. Jay Obernolte (CA-23)   Rep. John James (MI-10)   Rep. Cliff Bentz (OR-02)   Rep. Erin Houchin (IN-09)   Rep. Nick Langworthy (NY-23)   Rep. Tom Kean, Jr. (NJ-07)    Rep. Michael Rulli (OH-06)  Rep. Brett Guthrie (KY-02), Ex-Officio  Subcommittee on Oversight & Investigations:   Rep. John Joyce (PA-13), Chairman  Rep. Troy Balderson (OH-12), Vice Chairman  Rep. Gary Palmer (AL-06)  Rep. Dan Crenshaw (TX-02)  Rep. Randy Weber (TX-14)  Rep. Rick Allen (GA-12)  Rep. Russ Fulcher (ID-01)  Rep. Diana Harshbarger (TN-01)  Rep. Michael Rulli (OH-06)  Rep. Brett Guthrie (KY-02), Ex-Officio  ###

WASHINGTON, D.C.  – Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman Earl L. “Buddy” Carter (GA-01), Chairman of the Subcommittee on Health, announced a hearing titled Legislative Proposals to Maintain and Improve the Public Health Workforce, Rural Health, and Over-the-Counter Medicines. “The reauthorization of important programs, such as the Over-the-Counter Monograph Drug User Fee Program and vital public health programs, play a critical role in the Committee’s continued efforts to improve health care for Americans,” said Chairmen Guthrie and Carter. “Expanding patient access to safe over-the-counter drugs, allocating resources for rural providers, and supporting health care workforce development are among the many priorities of the Health Subcommittee, and we look forward to continuing the conversation and exploring future opportunities on ways to help Americans live healthier lives.”   Subcommittee on Health hearing titled Legislative Proposals to Maintain and Improve the Public Health Workforce, Rural Health, and Over-the-Counter Medicines.   WHAT : Subcommittee on Health hearing on Preserving Access to Timely and Affordable Care. DATE : Wednesday, July 9, 2025 TIME : 10:15 AM ET LOCATION : 2123 Rayburn House Office Building This notice is at the direction of the Chairmen. The hearing will be open to the public and press and will be live streamed online at  energycommerce.house.gov . If you have any questions concerning the hearing, please contact Annabelle Huffman with the Committee staff at Annabelle.Huffman@mail.house.gov . If you have any press-related questions, please contact Katie West at Katie.West@mail.house.gov . ###

WASHINGTON, D.C.  – Congressman Buddy Carter (GA-01), Chairman of the Subcommittee on Health, delivered the following opening statement at today’s hearing titled  The Fiscal Year 2026 Department of Health and Human Services Budget Subcommittee Chairman Carter's opening statement as prepared for delivery: “It is my pleasure to begin today’s hearing by welcoming the Secretary of Health and Human Services Robert F. Kennedy, Jr. to the House Energy and Commerce Committee Subcommittee on Health.  “Thank you, Secretary Kennedy, for coming before the Committee to discuss the Fiscal Year 2026 budget for the U.S. Department of Health an d Human Services.  “ In 2023, our nation spent an estimated $4.9 trillion on health care. That’s nearly 20 percent of our Gross Domestic Product. And when it comes to per-person health care spending, the United States far surpasses every other nation in the world.  “ And yet, America’s health outcomes still lag behind our peers. Life expectancy in the U.S. is lower than in other developed economies, and rates of infant and maternal mortality, obesity, diabetes, and heart disease are higher. At the same time, public trust in government health agencies has eroded.  “ The results of our record-breaking spending speak for themselves — and they’re unacceptable.   “ The system isn’t just expensive — it’s failing the very people it’s meant to serve.  “ Currently, in the United States, three in four adults experience one or more chronic conditions. In 2013, no state had adult obesity prevalence at or above 35 percent. Fast forward to 2023, 23 states had 35 percent or higher adult obesity rates. According to the CDC, in my home state of Georgia, 35 percent of adults are obese, and one in ten adults are living with three or more chronic conditions.    “ During my time as a pharmacist, I saw first-hand the toll that diet-related chronic diseases can have on individuals and families, due to rising health care premiums, out-of-pocket-costs, and missed work. The financial impact is astronomical – not to mention how taxing the physical, emotional, and mental burdens can be.   “ Just looking at the impact of diabetes, the United States spends more than $327 billion each year combatting the disease–with $237 billion spent on medical costs and another $90 billion in productivity losses.  “ America needs a new prescription — a clear, bold vision for the future. We can no longer afford to simply throw more money at this problem and hope for change. It is time to break from the old ways and embrace innovative, courageous ideas that will truly Make America Healthy Again.  “ I am looking forward to hearing more about how HHS is working to improve health care access for American patients and reduce provider burnout by leading on necessary changes to fix the broken health insurance prior authorization process.  “ I am also looking forward to hearing more about your agency’s plan to reduce unnecessary animal testing. So many of us here today are committed to a more efficient drug development process, and I am encouraged by the FDA’s Roadmap to reduce animal testing in preclinical safety studies through the use of innovative 21st-century science. “ As a supporter of the FDA Modernization Act 2.0 and the lead author of the FDA Modernization Act 3.0, I am excited to see that, under your leadership, the Department of Health and Human Services is building off of these proposals and leading the charge for the development of safe, effective treatments and therapies without unnecessary animal suffering. “ I look forward to hearing additional details of the Secretary’s proposal, and to continuing the dialogue between HHS and the Energy and Commerce Committee as we begin the budget process in earnest.  “ Again, I appreciate you being here today. I look forward to hearing how the proposed HHS budget will advance President Trump’s mission of Making America Healthy Again." ###

WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, along with Reps. Palmer (AL-06), Carter (GA-01), Bilirakis (FL-12), and Obernolte (CA-23), penned a letter to the Executive Director of Covered California (CoveredCA), Jessica Altman, to request further information related to the potentially unauthorized transmission of sensitive personal health information involving Covered California’s website. Key Letter Excerpt: “According to public reports and agency statements, tracking technology was embedded on Covered California's website beginning in February 2024, as part of a broader digital advertising effort, and in direct contravention of the tracking platform’s user agreement, which prohibits the use of such tools on pages that collect sensitive health information. Although the tags were reportedly removed in April 2025, following external scrutiny and a vendor transition, the extended period of data exposure raises serious questions about the adequacy of safeguards that Covered California had in place. Forensic testing by investigative reporters identified the trackers in operation and confirmed that user-entered health information was being transmitted to third parties without consent. These circumstances warrant examination of Covered California’s actions under federal privacy standards.” “Ensuring the confidentiality of health information is a foundational obligation for entities operating within the health insurance ecosystem. Federal privacy protections, particularly the Health Insurance Portability and Accountability Act (HIPAA), establish expectations for how covered organizations handle sensitive data. Recent reports and public filings raised questions about whether those expectations were met in this case, and whether existing oversight mechanisms are sufficient to detect and prevent improper disclosures.” Background: Forensic testing shows Covered California —the State of California’s official health insurance marketplace—has been sending sensitive user health data to third-party websites through several online data trackers. Prior to removal of the trackers, CoveredCA had more than 60 trackers active on its website; the average number of trackers on a government website is three. Some types of information sent to such websites include: Searches for doctors in network with specific plans/specializations Demographic information, including gender, ethnicity, and martial status Length of treatment a patent received by a provider Frequency of doctor visits If the user indicated they were blind, pregnant, a victim of domestic abuse, or used prescription medications. The State of California independently operates CoveredCA. As the state’s official ACA marketplace, CoveredCA falls under the purview of Health Insurance Portability and Accountability Act (HIPAA). The disclosure of information such as pregnancy or prescription drug use without proper consent—even for “marketing purposes”—may violate HIPAA. This Congress, the Committee has sent letters to 23andMe and DeepSeek over potential data privacy concerns: The Committee also held a hearing last Congress on the Change Healthcare hack, where personal health information was also jeopardized. CLICK HERE to read Fox News coverage of the letter. CLICK HERE to view the full letter. ###

Washington, D.C. — In a new letter to Department of Health and Human Services (HHS) Inspector General Christi Grimm, House Energy and Commerce Committee Republicans requested an investigation into the strength, quality, and types of evidence-based scientific and pediatric medical literature relied on by the department to promote gender transition procedures for children.  KEY LETTER EXCERPT:  “As the agency responsible for safeguarding the health and well-being of Americans, all of HHS’s medical treatment recommendations, especially medical treatment recommendations for children, should be based on rigorous and well-established research, such as randomized controlled trials, that have definitively illustrated the long-term benefits of gender affirming care treatments.”  BACKGROUND:  Under the Biden administration, HHS has advocated for sex reassignment procedures on minors, including the use of serum puberty blockers, which have historically been used to treat children with precocious puberty (i.e., early onset puberty affecting about one percent of U.S. children) and sex offenders.   Puberty blockers, however, are known to stunt normal childhood development in children unaffected by precocious puberty.  HHS officials contend that sex reassignment procedures on minors are an unanimously accepted medical practice.  HHS Secretary Becerra testified before Congress that “every major medical association,” “medical journals,” and “scientific and medical evidence” has demonstrated the benefits of transitioning children’s biological sex.  When asked, via a Freedom of Information Act request, for the underlying scientific or medical basis for its position, HHS was only able to produce a two-page brochure that was already publicly available.  In contrast to HHS, a growing body of literature from medical experts and authorities around the world, including those in Europe, caution against performing such procedures on minors.   Courts and government health agencies responsible for determining child welfare have sought to limit child sex reassignment procedures.   Other countries have banned these interventions and surgeries on minors altogether.  An article published in the British Journal of Medicine found “there is great uncertainty about the effects of puberty blockers, cross-sex hormones, and surgeries in young people.”   A court in the United Kingdom noted the obvious about administering puberty blocking chemicals onto children: “[i]t is highly unlikely that a child aged 13 or under would be competent to give consent to the administration of puberty blockers. It is doubtful that a child aged 14 or 15 could understand and weigh the long-term risks and consequences of the administration of puberty blockers.”  In April 2024, the Cass Review , an independent review of gender identity services for children and young people, commissioned by the National Health Service England, found “[w]hile a considerable amount of research has been published in this field, systematic evidence reviews demonstrated the poor quality of the published studies, meaning there is not a reliable evidence base upon which to make clinical decisions, or for children and their families to make informed choices.”   The Cass Review also found that “[t]he rationale for early puberty suppression remains unclear, with weak evidence regarding the impact on gender dysphoria, mental or psychosocial health,” as well as unknown effects on cognitive and psychosexual development.  In August 2024, the American Society of Plastic Surgeons (ASPS) became the first major U.S. medical association to express caution on the use of gender surgery for gender dysphoria in adolescents. In its formal statement, the association stated: “ASPS currently understands that there is considerable uncertainty as to the long-term efficacy for the use of chest and genital surgical interventions for the treatment of adolescents with gender dysphoria, and the existing evidence base is viewed as low quality/low certainty. This patient population requires specific considerations.”   The letter was signed by Committee Chair Cathy McMorris Rodgers (R-WA), Subcommittee on Health Chair Brett Guthrie (R-KY), Subcommittee on Oversight and Investigations Chair Morgan Griffith (R-VA), Rep. Dan Crenshaw (R-TX), Rep. Gus Bilirakis (R-FL), Rep. Buddy Carter (R-GA), Rep. Gary Palmer (R-AL), Rep. Neal Dunn (R-FL), Rep. Randy Weber (R-TX), Rep. Troy Balderson (R-OH), Rep. August Pfluger (R-TX), Rep. Diana Harshbarger (R-TN), and Rep. Kat Cammack (R-FL).  CLICK HERE to read the letter.

House Republicans scrutinize government grant funding recipients that fail to protect individuals from antisemitism Washington, D.C. — In a new letter to J. David Gladstone Institutes President Dr. Deepak Srivastava, the House Committee on Energy and Commerce (E&C) and House Committee on Education and the Workforce (E&W) have requested information about ongoing and pervasive acts of antisemitic harassment and intimidation at Gladstone and its leadership’s insufficient response to these acts. The letter is signed by E&C Chair Cathy McMorris Rodgers (R-WA), E&C Subcommittee on Health Chair Brett Guthrie (R-KY), E&C Oversight and Investigations Subcommittee Chair Morgan Griffith (R-VA), E&W Chair Virginia Foxx (R-NC), and E&W Subcommittee on Higher Education and Workforce Development Chair Burgess Owens (R-UT).  KEY LETTER EXCERPTS: “The Gladstone Institutes, an independent biomedical research organization, claims that it takes an active stance against serious issues like discrimination and harassment and aims to ‘ensure all community members at Gladstone feel included’ and that the Institutes will aim to ‘implement accountability measures and reinforce Gladstone’s commitment to having an environment free of harassment.’ However, these values do not seem to be reflected in the actions of leadership in response to recent concerns of antisemitic harassment and discrimination within the Institutes.” [...] “The reports of antisemitic harassment at Gladstone coupled with the inadequate response by leadership is concerning to the Committees. Failing to act decisively to ensure a safe environment for all trainees, faculty, and staff is a grave dereliction of your responsibilities as President of Gladstone.” “Failing to comply with basic safety protections for members of Gladstone or failure to respond appropriately to and prevent harassment and discrimination, no matter the cause, may be grounds to withhold federal funds from the university. Congress has an obligation to exercise oversight of recipients of federal funds when blatant and ongoing Title VI violations appear to be happening. If Congress determines an institution of higher education/research is blatantly ignoring its legal responsibilities, we may consider rescinding research and development funds previously appropriated.” BACKGROUND ON TAXPAYER FUNDING: Gladstone received more than $41 million in funding from the NIH in Fiscal Year 2023, not including potential taxpayer funding that individual faculty may have received through their affiliation with the University of California, San Francisco (UCSF) or any other affiliated universities.   According to the NIH’s Grant Policy Statement, any institution receiving federal funds must assure work environments are free of discriminatory harassment and are safe and conducive to high-quality work.  Institutions receiving federal taxpayer financial assistance—such as NIH grants—are prohibited from discriminating based on a variety of categories, including national origin.   These laws also protect members of the institution who are or are perceived to be members of a group with shared ancestry, such as students/trainees of Jewish heritage. BACKGROUND ON INSTANCES OF ANTISEMITISM : Two days after the October 7, 2023, Hamas terrorist attack, a graduate student working in a lab within Gladstone sent an antisemitic email to all Gladstone faculty, trainees, and staff falsely stating that the attack on innocent Israeli civilians was “the resistance in Gaza launch[ing] a surprise attack against Israel, taking occupation soldiers hostage, taking over Israeli military vehicles, and gain[ing] control over illegal Israeli settlements.”  The email goes on to claim that all casualties resulting from Palestinian actions are the responsibility of Israel.  Immediately following this mass email, members of the Gladstone faculty began contacting the Gladstone Institutes’ President and other leadership, appalled by the language of the email, concerned for their safety and worried that the email could be seen as an incitement to violence.  Jewish members of the Institutes also expressed their deep, personal pain following the Hamas attack, as some members had family or friends reported killed or missing directly after the attack.  These fears—including fears of being attacked in the lab by the author of this cruel and antagonistic email—were shared directly with President Srivastava.  Despite this, Gladstone leadership did not issue a public statement or position against antisemitism to quell fears of Jewish faculty and trainees.  In May 2024, the Center for Combatting Antisemitism sent President Srivastava a letter requesting administrative action to address the hostile environment and disparate treatment of Jewish members at Gladstone.  This letter noted that Gladstone refused to acknowledge Jewish American Heritage Month, Passover, or Holocaust Remembrance Day, despite sending official celebratory emails and holding events for other religious, ethnic, or national holidays, including Black History Month, International Women’s Day, and Ramadan.  The Center followed up with Gladstone several times, but never received a response.  Jewish faculty and trainees have conveyed to leadership within Gladstone instances of antisemitic harassment and discrimination, which faculty and trainees believe were not taken seriously, making some feel uneasy about speaking out.  For example, per a publicly available Fair Employment and Housing Act complaint to the California Civil Rights Division, a Jewish faculty member openly discussed fellow faculty using racial stereotypes, including comments about a “Jewish nose.”  When these comments were brought to human resources, no investigation occurred.  Instead, the complainant was subsequently targeted with an investigation ultimately deemed to be unwarranted.  Then, following the complainant’s post-October 7th advocacy on behalf of Jewish faculty and trainees, the complainant was threatened repeatedly with career-ending termination, allegedly in an attempt to extort a resignation.  When the threats did not have their desired effect, Gladstone placed the complainant on administrative leave and removed the complainant’s electronic access to email and files but also physical access to the complainant’s lab, removing all ability to conduct work on an NIH-funded grant.  Gladstone ultimately paid an undisclosed sum to settle the matter and avoid litigation.  To elevate concerns regarding widespread, ongoing discrimination, Jewish faculty and trainees requested permission to bring in a speaker related to antisemitism.  Other minority groups had previously been given permission to bring in similar anti-racism speakers.  However, while leadership stated it would look into the idea, ultimately no speaker was brought, and no program was launched regarding antisemitism. BACKGROUND ON AFFILIATIONS WITH OTHER INSTITUTIONS UNDER INVESTIGATION : Gladstone Institutes is affiliated with other institutions under congressional investigation.  For example, Gladstone is an affiliate of the UCSF, which is undergoing congressional investigation for reports of antisemitism within the university, medical school, and medical centers.  Most of Gladstone’s principal investigators are also faculty at UCSF, and the Institutes provide research positions and opportunities for graduate students from UCSF.  Moreover, there is a joint institute—the Gladstone-UCSF Institute of Genomic Immunology—further linking the two institutions.  Gladstone is also affiliated with the University of California, Berkeley and Stanford University, both of which are also under investigation for concerns related to antisemitism. CLICK HERE to read the full letter.